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ABSTRACT
Systemic lupus erythematosus (SLE) is a systemic autoimmune inflammatory disease. It presents with a myriad of clinical manifestations affecting 
every other organ system in the human body. The gastrointestinal (GI) system is one of the most commonly affected systems and it involves any part 
of the GI tract with an incidence ranging from 1.3% to 27.5%. GI manifestations as a presenting feature of SLE are unusual. Chronic diarrhea due to 
protein-losing enteropathy as the presenting manifestation of SLE is very rare, and a diagnosis of SLE should be kept in mind when other systemic 
manifestations are absent. Hence, we report a 29-year-old female with chronic diarrhea as the main manifestation of SLE.
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INTRODUCTION
Systemic lupus erythematosus (SLE) is a systemic autoimmune 
inflammatory disease. It presents with myriad of clinical manifestations 
affecting every other organ system in the human body. It is very common 
in female population presenting with varied clinical manifestations 
in about 90% [1]. The gastrointestinal (GI) system is one of the most 
commonly affected systems and it involves any part of the GI tract 
with an incidence ranging from 1.3% to 27.5% [2,3]. However, most GI 
manifestations are mainly due to adverse reactions from drugs used 
therapeutically and infections. The symptoms related to the disease 
per se are very common as compared to other organ involvements 
such as lupus nephritis. Diarrhea in patients with SLE generally can 
be due to parasitic or bacterial intestinal infections and because of 
chronic pancreatitis or drugs such as azathioprine [4,5]. Diarrhea due 
to rare complications of SLE includes protein-losing enteropathy, lupus 
enteritis, intestinal pseudo-obstruction, eosinophilic enteritis, and 
celiac disease [6]. Here, we report a 29-year-old female with chronic 
diarrhea as the main manifestation of SLE.
CASE REPORT
Informed consent was taken from patient. A 29-year-old female 
presented with complaints of diarrhea for 2 months. Diarrhea episodes 
were 8-10 times/days, watery, large-volume not associated with blood 
or mucus. Occasional episodes of vomiting were present. She had weight 
loss of 15 kg in the last 2 months. There was no history of fever, rash, 
or arthralgia. On examination, vitals were stable. Systemic examination 
was unremarkable, except for mild periumbilical tenderness. Initial 
blood investigations showed normal blood count (Table 1) and blood 
urea and creatinine levels were also normal (Table 2). Stool microscopy 
was negative for white blood cell and parasites. Liver function showed 
hypoalbuminemia (2.6 g/dL) and transaminases were elevated to 
two times the upper limit of normal (Table 2). Urine spot protein 
was negative. In view of hypoproteinemia and negative proteinuria, 
contrast-enhanced computed tomography (CECT) abdomen was done 
and CT findings revealed diffuse bowel wall edema with small capacity 
urinary bladder and mild bilateral hydroureteronephrosis (Fig. 1). 
The possibility of vasculitis or a collagen disorder was suspected. 
Upper GI endoscopy was normal. Antinuclear antibody serology was 
strongly positive with anti-ds-DNA positivity detected by indirect 
immunofluorescence.
She was initiated on injectable methyl prednisolone and changed 
over to oral prednisolone. Patient’s symptom showed marked 
improvement. Two weeks later, she presented with pedal edema and 
facial puffiness. Evaluation showed nephrotic range proteinuria. Renal 
biopsy was suggestive of lupus nephritis. She was treated with pulse 
cyclophosphamide, on which she went into remission.
DISCUSSION
SLE is an autoimmune inflammatory disease. It is usually characterized 
by autoantibodies and immune complex formation. Every system and 
organ can be affected by SLE. The disease is predominant in women 
as compared to men with a reported female:male ratio of 10:1.1. In 
1895, physician William Osler described the GI complications of SLE 
and how it mimics other abdominal conditions and completely masks 
the other organ complications associated with SLE [6]. GI complications 
can cause myriad of symptoms across the GI tract. Patients usually 
experience diarrhea, anorexia, nausea, or vomiting. GI symptoms are 
common in SLE patients and are secondary to side effects of drugs 
used for treatment and due to viral or bacterial infections. It is not as 
common as lupus nephritis. GI involvement in SLE is highly important 
as mortality rates are high if patients are not treated promptly. 
Lupus mesenteric vasculitis is the most common cause, followed 
by protein-losing enteropathy, intestinal pseudo-obstruction, acute 
pancreatitis, and other rare complications such as celiac disease and 
inflammatory bowel diseases. Specific autoantibody associated with 
SLE-related gastroenteropathy has not been identified. Abdominal 
computed tomography scans are very helpful in diagnosing. Good 
therapeutic responses to corticosteroids and immunosuppressive 
agents are usually seen. Supportive measures include bowel rest, 
nutritional support, antibiotics, and prokinetic medications. It helps in 
recovering the function of bowel and improving therapeutic outcome. 
Protein-losing gastroenteropathy (PLGE) is characterized by edema 
and severe hypoalbuminemia secondary to excessive loss of from 
the bowel. It is clinically indistinguishable from nephrotic syndrome. 
It is very uncommon in SLE. So far, only 60 patients with SLE-related 
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PLGE have been reported in the literature. It is predominant among 
the Asians and whether genetics or environmental factors play a role 
in it remains to be elucidated. PLGE has a female predominance and 
can affect any age group. The clinical manifestations of PLGE develop 
before the diagnosis of SLE. Gornisiewicz et al. [7] found PLGE is 
usually associated with multiorgan system involvement in SLE. Mucosal 
ulceration, non-necrotizing mesentericor intestinal blood vessel 
vasculitis, increase in capillary permeability caused by intravascular 
activation and conversion of complement, cytokine-mediated (such as 
tumor necrosis factor-α and interleukin-6) or complement-mediated 
vascular or mucosal damage, and intestinal lymphangiectasia have 
been postulated as the pathogenic mechanisms [8-10]. In our case, 
patient had diarrhea, vomiting, and weight loss for 2 months without a 
history of fever, arthralgia. Hypoalbuminemia was noted. Other causes 
of diarrhea were ruled out and CECT abdomen showed edematous 
bowel loops. Upper GI endoscopy was also normal. Patient was positive 
for anti-ds antibody. Hence, a diagnosis of protein-losing enteropathy 
due to SLE was made and the treatment was initiated. Patient was 
started on intravenous methyl prednisolone and changed over to oral 
form; there was a marked improvement in the condition of patient, and 
after 2 weeks, patient presented with pedal edema and facial puffiness. 
Laboratory evaluation revealed nephrotic range proteinuria and renal 
biopsy confirmed lupus nephritis. The patient was successfully treated 
with cyclophosphamide.
CONCLUSION
SLE is one of the most common connective tissue disorders in females. 
GI manifestations as a presenting feature of SLE are unusual. Chronic 
diarrhea due to PLE as the presenting manifestation of SLE is very rare, 
and a diagnosis of SLE should be kept in mind when other systemic 
manifestations are absent. The case highlights the importance of 
suspecting uncommon presentations of common diseases whenever 
there is a dilemma in the arriving at a plausible and valid diagnosis.
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WBC: White blood cell, ESR: Erythrocyte sedimentation rate
Table 2: Laboratory investigations
Albumin - serum 2.6 g/dL
Globulin - serum 4.1 g/dL
Alkaline phosphatase - serum/plasma 132 U/L
Alanine transaminase - serum/plasma 65 U/L
Aspartate transaminase - serum 62 U/L
GGTP 38 U/L
Glucose - serum/plasma (random) 90 mg/dL
Creatinine - serum/plasma 0.7 mg/dL
Urea - serum/plasma 33 mg/dL
Sodium - serum/plasma 135 mEq/L
GGTP: Gamma glutamyl transpeptidase 
Fig. 1: Contrast-enhanced computed tomography (CT) of  
abdomen showing diffuse bowel wall edema with small capacity 
urinary bladder and mild bilateral hydroureteronephrosis
